tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (DE:1NP1)
:1NP1
Germany Market

InDex Pharmaceuticals Holding AB (1NP1) Cash flow

Compare
3 Followers

InDex Pharmaceuticals Holding AB Cash Flow

DE:1NP1's free cash flow for Q1 2025 was kr-18.20M. For the 2025 fiscal year, DE:1NP1's free cash flow was decreased by kr20.98M and operating cash flow was kr-18.20M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -17.00Mkr -37.98Mkr -129.44Mkr -124.06Mkr -70.65M
Investing Cash Flow
kr -19.80Mkr -625.20Mkr 0.00kr 0.00kr -909.00K
Financing Cash Flow
kr 571.90Mkr 634.70Mkr -818.00Kkr 486.39Mkr -1.40M
End Cash Position
kr 865.10Mkr 294.27Mkr 344.93Mkr 428.45Mkr 53.83M
Free Cash Flow
kr -17.00Mkr -37.98Mkr -129.44Mkr -124.06Mkr -71.56M
Currency in SEK

InDex Pharmaceuticals Holding AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis